Business Of Biotech

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.

The Implications Of China's Growing Biotech Industry With Allan Shaw
Apr 21, 2025 – 46:08
How To Be A CFO With Insmed's Sara Bonstein
Apr 14, 2025 – 44:20
Deal And Investment Trends With Investment Banker David Sans
Apr 7, 2025 – 46:43
Business of Biotech 2.0 with Ben Comer
Mar 31, 2025 – 34:44
BoB@JPM: Nima Farzan, Latigo Biotherapeutics
Mar 24, 2025 – 43:32
BoB@JPM: Kasper Roet, Ph.D., QurAlis
Mar 17, 2025 – 43:46
BoB@JPM: Rick Modi, Affinia Therapeutics
Mar 10, 2025 – 52:20
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty
Mar 3, 2025 – 56:27
BoB@JPM: Tom Chalberg, Ph.D., Genascence
Feb 24, 2025 – 48:00
BoB@JPM: Ran Zheng, Landmark Bio
Feb 17, 2025 – 37:00
BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics
Feb 10, 2025 – 45:07
BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience
Feb 3, 2025 – 43:00
The Business Of CNS with Acumen's Jim Doherty, Ph.D.
Jan 27, 2025 – 47:51
High-Throughput Discovery With Bioptic's Andrey Dobry
Jan 20, 2025 – 01:13:36
RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.
Jan 13, 2025 – 01:06:32
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal)
Jan 6, 2025 – 54:04
Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D.
Dec 30, 2024 – 01:02:34
Biotech Story Time With Tal Zaks, M.D. (Part 1)
Dec 23, 2024 – 55:25
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
Dec 16, 2024 – 52:50
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski
Dec 9, 2024 – 01:03:50
Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.
Dec 2, 2024 – 45:26
Biopolitics With Allan Shaw
Nov 25, 2024 – 49:54
T-Cells For The Win With Adaptimmune's Adrian Rawcliffe
Nov 18, 2024 – 01:01:35
Serving The Underserved With Gates MRI's Claire Wagner, M.D.
Nov 11, 2024 – 46:48
An Unanticipated Biotech Startup With OS Therapies' Paul Romness
Nov 4, 2024 – 49:12
Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright
Oct 28, 2024 – 44:14
Obesity Tx End-Around With Skye Bioscience's Punit Dhillon
Oct 21, 2024 – 01:02:41
Biotech C-Suite Construction With Allan Shaw
Oct 14, 2024 – 51:34
The Peptide Promise With NervGen's Mike Kelly
Oct 7, 2024 – 59:19
Biotech Course Correction With Treehill Partners' Ali Pashazadeh
Sep 30, 2024 – 01:17:16
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.
Sep 23, 2024 – 01:14:26
Picking Biotech Jockeys With SR One's Simeon George, M.D.
Sep 16, 2024 – 54:03
Embracing Biotech Chaos With Memo's Erik van den Berg
Sep 9, 2024 – 54:05
Pivoting To RNA With Circio's Dr. Erik Digman Wiklund
Sep 2, 2024 – 01:04:47
mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.
Aug 26, 2024 – 01:03:07
Steering Through Setbacks with AVEO Oncology's Michael Bailey
Aug 19, 2024 – 58:06
Leading From Within with ISCT & Kiji's Miguel Forte, M.D.
Aug 12, 2024 – 59:37
The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.
Aug 5, 2024 – 01:04:44
Expanding The Proteome with ProFound's John Lepore, M.D.
Jul 29, 2024 – 56:38
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné
Jul 22, 2024 – 01:06:39
First AI Antibody In Humans with Aulos' Aron Knickerbocker
Jul 15, 2024 – 01:08:52
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs
Jul 8, 2024 – 01:12:31
Topical Ocular Biologics with Claris Bio's Clarke Atwell
Jul 1, 2024 – 58:06
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley
Jun 24, 2024 – 01:04:02
True DEI Value in Biopharma with Arcellx's Rami Elghandour
Jun 17, 2024 – 01:04:08
Mission-Driven Dementia Funding with DDF's Jonathan Behr
Jun 10, 2024 – 55:46
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller
Jun 3, 2024 – 01:04:06
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
May 27, 2024 – 56:38
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
May 20, 2024 – 57:35
A New Prescription For PBMs with Allan Shaw
May 13, 2024 – 40:13

Recent Reviews

ladyscientistpodcast

great interview with bit.bio

Enjoyed your latest episode with bit.bio’s Mark Kotter!
Boddiingsytikgd

Timely news & interesting guests

A great way to stay up to date with all that is happening in the biotech world. Lively discussions as the host Matt has unfiltered chats with top industry icons. Best podcast I’ve found in this field!
Glleee

Episodes are great, Newsletter no no no

I learn so much every episode. The recent episode featuring Recursion was especially helpful. The only annoying thing, I signed up for the newsletter after all the talk about it not being “another newsletter” but it’s actually worse than most. WAY too many headlines, poor formatting makes it hard to follow or focus on any particular one, the thing is poorly designed and packed with jargon.
Woodenlunch

Great format!

Excellent conversational podcast that is both wide ranging and specific to the key issues facing biological drug developers
Memes34618

New fav

My new favorite pod!
T-Mann77

Engaging and Enlightening!

This is one of my favorite podcasts in the life sciences space! The host, Matt Pillar is dynamic and engaging, the thought leaders that he chats with are some of the most knowledgeable in the world, and the insights shared in each episode is invaluable!
MilesSz

Great since episode 1

I’ve been listening to this podcast since episode 1 and it’s been amazing. The guests are great and the right people I want to hear from and the host is exceptional. If you are in the industry this is the best podcast by far.
buck025

A Great Listen

Great guests, great conversations, and so much more. Host Matt Pillar does a great job of keeping the conversation on point and quick paced. I’m new to the industry and have learned a great deal thanks to this podcast.
Derek VS

Hard to find insights

Matt’s guest list is a five star tour de force biotech execs. There’s no better source of insights into how these leaders think, work, and bring their therapies to life.
MoodyPooty

The Best

The best podcast for understanding the biotech space. Required listening for anyone involved with biotech.
Trevor Oldham

Awesome!

One of my new fav podcasts!
A. Dua

Dynamic and engaging

This podcast has a variety of guest speakers which has made listening to it very enjoyable and engaging.
Erie Train Fan

A must-listen for the biopharma industry

Matt Pillar brings NPR-level talent and a refreshing take on the top issues facing biopharma companies today. The episodes fly by, have a congenial/conversational feel. A bonus is that the discussions provide specific data points and takeaways for listeners.
SDSU.aztecs

Great Podcast for Biotech Prossionals

Found this podcast as I prepared for a position with a big Pharma company and found Matt’s interviews to shed light on some of the strategies and tactics of the professionals/ firms in the field. Great way to understand how science is and can be accomplished beyond the scientific headlines and papers.